4//SEC Filing
PLx Pharma Inc. 4
Accession 0001144204-17-021380
CIK 0001497504operating
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 9:15 PM ET
Size
7.7 KB
Accession
0001144204-17-021380
Insider Transaction Report
Form 4
PLx Pharma Inc.PLXP
Giordano Natasha
DirectorCEO
Transactions
- Award
Common Stock
2017-04-19+1,086→ 1,086 total - Award
Options
2017-04-19+216,580→ 216,580 totalExercise: $12.44Exp: 2025-09-25→ Common Stock (216,580 underlying)
Footnotes (3)
- [F1]Received in exchange for 1,380 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the "Merger") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.).
- [F2]Received in connection with the Merger in exchange for an employee stock option to buy 275,000 shares of PLx Opco Inc. common stock for $9.80 per share.
- [F3]The option is exercisable as to 108,290 shares as of the date hereof, and will become exercisable as to an additional 54,145 shares on each of January 1, 2018 and (subject to continued employment through such date) January 1, 2019.
Documents
Issuer
PLx Pharma Inc.
CIK 0001497504
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001497504
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 9:15 PM ET
- Size
- 7.7 KB